Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.
Explore this paper's citation graph
Summary
The viral load is the chief predictor of the risk of heterosexual transmission of HIV-1, and transmission is rare among persons with levels of less than 1500 copies of HIV -1 RNA per milliliter.
- Type
- article
- Published
- 2000-03-30
- Cited by
- 2,573
- References
- 43
- Access
- Open access
- OpenAlex
- https://openalex.org/W2314461521
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:27251875
Keywords
Seroconversion, Medicine, Incidence (geometry), Transmission (telecommunications), Demography
References
- Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner.
- Factors associated with changes in HIV shedding in semen.
- The design and analysis of cohort studies
- Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
- Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV.
- Coreceptors--Implications for HIV Pathogenesis and Therapy
- Quantification of HIV in semen: correlation with antiviral treatment and immune status
- Potential for the transmission of HIV-1 despite highly active antiretroviral therapy.
- Male circumcision and HIV infection: 10 years and counting.
- Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis.
- Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group.
- Male circumcision: assessment of health benefits and risks.
- Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.
- Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.
- From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.
- Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.
- Epidemiologic evidence for time variation in HIV infectivity.
- Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
- Global burden of the HIV pandemic.
- Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions.
Cited by
- Editorial: HIV partner notification: a neglected prevention intervention.
- VIH : comment la recherche en épidémiologie s’est orientée de l’évaluation thérapeutique au dépistage et à la prévention
- Antiretroviral therapy for HIV-infected people in Papua New Guinea: challenges and opportunities.
- Overview of effective and promising interventions to prevent HIV infection.
- Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
- Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection
- Genital shedding of HIV-1 despite successful antiretroviral therapy.
- Acute Human Immunodeficiency Virus Infection Presenting as Disseminated Gonococcal Infection
- Evidence-based prevention: increasing the efficiency of HIV intervention trials.
- ADOLESCENT SEXUALITY AND THE HIV EPIDEMIC IN YAOUNDÉ, CAMEROON
- Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
- Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy.
- Reducing HIV-1 transmission through prevention strategies targeting HIV-1-seropositive individuals.
- Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors
- HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples
- Comparative antiviral and proviral factors in semen and vaccines for preventing viral dissemination from the male reproductive tract and semen
- Use of predictive markers of HIV disease progression in vaccine trials.
- Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study
- Determining Seminal Plasma Human Immunodeficiency Virus Type 1 Load in the Context of Efficient Highly Active Antiretroviral Therapy
- Sexual risk taking among patients on antiretroviral therapy in an urban informal settlement in Kenya: a cross-sectional survey
Related papers
- Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome
- Viral Load and CD4 Count Dynamics After HIV-1 Seroconversion in Homosexual and Bisexual Men in Rio de Janeiro, Brazil
- Trends in Post-Infection CD4 Cell Counts and Plasma HIV-1 RNA Levels in HIV-1–Infected Patients in France Between 1997 and 2005
- Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load.
- HIV RNA level in early infection is predicted by viral load in the transmission source
- Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study.
- Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters
- Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group.
- Performance of serological assays for early detection of human immunodeficiency virus type 1 seroconversion
- Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.